Bookmark This Page

Delicious Google Bookmarks Stumbleupon Digg BlinkList Ma.gnolia Reddit Yahoo My Web

Abdominal Chemotherapy Sheds Hope On Ovarian Cancer

A recent ovarian cancer study reported that injections of chemotherapy drugs directly into the abdominal cavity increase survival for those with advanced ovarian cancer by about one year. Apparently these study results were solid and promising enough that the National Cancer Institute is asking doctors to start administering abdominal chemotherapy as an additional treatment to IV chemotherapy.

Historically, the National Cancer Institute has not made such impacting statements of confidence and action very often. It appears that the benefits of abdominal chemotherapy are so great that a stronger endorsement of this new administration of chemotherapy be known about and available to women suffering with ovarian cancer.

With abdominal chemotherapy traditional chemotherapy drugs are used, but are injected much closer to the site of ovarian cancer. Higher doses of the chemotherapy drugs are able to penetrate the ovaries and abdominal cavity.

Treatment usually involves six cycles of both abdominal chemotherapy and intravenous chemotherapy. The side effects of chemotherapy can leave some women simply too weak or with a loss of spirit that they are unable or unwilling to carry out a full round of treatment. The important thing is that even incomplete chemotherapy and abdominal chemotherapy treatment drastically improves the odds of survival.

Historically, ovarian cancer has a fifty percent death rate for those diagnosed with ovarian cancer within five years. These odds may be changed significantly with this new form of chemotherapy treatment for ovarian cancer. For more information, visit http://MayoClinic.com. There are many articles about the current technology and treatment types available as well.